journal article·1999-07

Synthesis of New Poly(N-Vinyl Pyrrolidone-Co-Maleic Acid) Peptide Hormone Conjugates with Anticancer Activity

János Pató, Melinda Móra, Imre Mezö, János Seprödi, István Teplán, Borbála Vincze, Adrienn Kálnay, István Pályi

Publisher page

Abstract

Gonadotropin releasing hormone (GnRH) is a decapeptide regulating the gonadotropin release in organisms. Its analogues inhibit breast, endometrium and prostatic tumor cell proliferation in vitro. Some analogues were conjugated via the lysine side chain to poly( N-vinyl pyrrolidone- co-maleic acid) using biodegradable and non-biodegradable oligopeptide spacers. The conjugates were prepared by acylation of oligopeptide nitrophenyl esters with the polymeric precursor, poly( N-vinyl pyrrolidone- co-maleic anhydride), by reacting the GnRH analogues with the polymeric active ester. In vitro tests of these products exhibited increased effects on MCF-7 and MDA MB-231 breast, Ishikawa endometrium and PC3 prostatic human tumor cells compared with the parent decapeptides.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Chemical Synthesis and Analysis · Biopolymer Synthesis and Applications · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Central Research Institute for Chemistry, POB 17 1525, Budapest, Hungary

Semmulweis University Medical School, Puskin u. 9 1080, Budapest, Hungary

National Institute of Oncology, Ráth Gy. u. 7-9 1122, Budapest, Hungary

References (20)

Show source-provided references
1. 1. K. H. Kim, T. Hirano, and S. Ohashi. In J.C. Salamone (ed.), Encyclopedia of Polymer Science, CRC Press, Boca Raton, FL, 1996 vol. 1, pp. 272-285.
2. 10.1007/3540587888_1410.1007/3540587888_14 ↗
3. 10.2165/00003088-199427040-0000410.2165/00003088-199427040-00004 ↗
4. H. Maeda · Crit. Rev. in Ther. Drug Carrier Syst. · 1995 · 6 · 193
5. 10.1016/0032-3861(77)90162-810.1016/0032-3861(77)90162-8 ↗
6. 10.1177/08839115910060020510.1177/088391159100600205 ↗
7. 10.1002/macp.1989.02190082010.1002/macp.1989.021900820 ↗
8. 10.1002/marc.1982.03003091110.1002/marc.1982.030030911 ↗
9. 9. J. Pitha. In E.P. Goldberg (ed.), 1983. Targeted Drugs J. Wiley, New York, pp. 113.
10. 10.1016/0378-5173(96)04538-310.1016/0378-5173(96)04538-3 ↗
11. 10.1021/bc960057410.1021/bc9600574 ↗
12. 10.1074/jbc.271.36.2196910.1074/jbc.271.36.21969 ↗
13. 10.1073/pnas.86.5.164810.1073/pnas.86.5.1648 ↗
14. 10.1016/0960-0760(91)90116-M10.1016/0960-0760(91)90116-M ↗
15. I. Pályi · Cancer Detection and Prevention · 1996 · 20 · 146
16. B. Vincze · Cancer Detection and Prevention · 1996 · 20 · 153
17. 10.1016/0142-9612(85)90037-710.1016/0142-9612(85)90037-7 ↗
18. 18. J. Pató, K. Ulbrich and J. Kopecek. Unpublished result.
19. I. Mezö · Biomed. Peptides, Proteins & Nucleic Acids · 1996 · 2 · 33
20. S. Lovas · J. Peptide Res. · 1998 · 54 · 38410.1111/j.1399-3011.1998.tb00662.x ↗